Onco-Innovations Limited ONNVF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.70K | 79.90K | 110.50K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.70K | 79.90K | 110.50K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 65.70K | 79.90K | 110.50K | -- | -- |
| SG&A Expenses | 5.06M | 4.53M | 4.75M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.25M | 5.45M | 5.53M | -- | -- |
| Operating Income | -6.18M | -5.37M | -5.42M | -- | -- |
| Income Before Tax | -8.27M | -7.80M | -10.02M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.27 | -7.80 | -10.02 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.27M | -7.80M | -10.02M | -- | -- |
| EBIT | -6.18M | -5.37M | -5.42M | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.15 | -0.14 | -0.19 | -- | -- |
| Normalized Basic EPS | -0.09 | -0.09 | -0.09 | -- | -- |
| EPS Diluted | -0.15 | -0.14 | -0.19 | -- | -- |
| Normalized Diluted EPS | -0.09 | -0.09 | -0.09 | -- | -- |
| Average Basic Shares Outstanding | 229.29M | 221.87M | 212.28M | -- | -- |
| Average Diluted Shares Outstanding | 229.29M | 221.87M | 212.28M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |